- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07197476
- Original Trial
Adolescent Stress and Substance Intervention Subsequent to Trauma (ASSIST)
Adolescent Injury: Intervening to Prevent Posttraumatic Stress and Substance Use Outcomes
The long-term goal of this study is to address the adoption of the new trauma center requirement to establish best practices of screening for acute stress with an intervention to prevent both adolescent PTSD and substance use. The investigators will develop, refine, and pilot test the Adolescent Stress and Substance Intervention Subsequent to Trauma (ASSIST) video interventions that build upon the American College of Surgeons Committee on Trauma guidelines to improve mental health care during and after hospitalization for traumatic injury. The aims are:
PHASE I - Primary Aim 1: To develop and refine two ASSIST video interventions for adolescents and parents admitted to a level 1 pediatric trauma center.
PHASE II
- Primary Aim 2a: To evaluate the feasibility, acceptability and implementation potential of the ASSIST video interventions.
- Primary Aim 2b: Develop the ASSIST implementation protocol using a national advisory panel of pediatric trauma center leaders.
Participants in PHASE 1:
Parent and child duo:
- Review storyboards for the video interventions
- Participate in qualitative interviews at hospital admission and 1 month following discharge
Pediatric trauma center clinical staff members:
- Complete qualitative interviews
Participants in PHASE II:
Parent and child duo:
- Shown their own video interventions
- Complete assessments at admission and 1-, 2-, 3- months after discharge
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Recruiting
- Rhode Island Hospital
-
Contact:
- Michael J Mello, Doctor of Medicine
- Phone Number: 401-519-0330
- Email: mjmello@brownhealth.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria for Youth:
- Must be 12-17 years
- Fluent in English or Spanish
- Able to provide informed assent
- Have a parent able to provide informed consent
Inclusion Criteria for Parents:
- Live with an admitted pediatric trauma patient
- Fluent in English or Spanish
- Able to provide informed consent
Exclusion Criteria:
- Prisoner or in police custody
- Involvement with child protective services
- Admitted due to suicide attempt or non-suicidal self-injury
- Any acute condition that would preclude provision of informed consent or assent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Develop and Pilot Test ASSIST Video Intervention
The investigators will develop and pilot test the Adolescent Stress and Substance Intervention Subsequent to Trauma (ASSIST) video intervention that builds upon ACS-COT guidelines to improve mental health care during and after hospitalization for traumatic injury.
The ASSIST video intervention is a simple, cost-effective, and scalable tool that may be easily integrated into usual care settings to address posttraumatic symptoms and decrease risk of subsequent substance use following discharge.
|
Video intervention for participants: adolescent trauma patient-parent dyads.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Develop the ASSIST implementation protocol
Time Frame: 3 months
|
Develop the ASSIST implementation protocol using a national advisory panel of pediatric trauma center leaders.
Using an expert panel from the national cohort of pediatric trauma centers the investigators have worked with in a previous implementation trial, and pilot data from the investigators' institution, an implementation protocol will be developed that will be tested in a subsequent fully powered R01 hybrid implementation-efficacy trial.
|
3 months
|
|
To develop and refine two ASSIST video interventions for adolescents and parents admitted to a level 1 pediatric trauma center.
Time Frame: Single interaction for enrollment and qualitative interview up to 45 minutes
|
Elicit feedback from content experts to further refine initial ASSIST video interventions. Conduct qualitative interviews with 15-20 parents and adolescents (12-17 years) to assess perceived usefulness of, and satisfaction with, intervention content as well as elicit feedback on areas for future refinement. Conduct qualitative interviews with 9-12 key stakeholders in the fields of pediatric trauma care to assess clinical concerns/strategies as well as implementation barriers/facilitators. |
Single interaction for enrollment and qualitative interview up to 45 minutes
|
|
To evaluate the feasibility, acceptability, and implementation potential of the ASSIST video interventions.
Time Frame: From enrollment to the end of the surveys and exit interview at 3 months
|
Examine the feasibility and acceptability of the ASSIST videos, over a 3-month period, as measured by rates of enrollment and retention, interest/satisfaction, knowledge regarding mental health symptoms/substance use, incidence (quantity/frequency) of substance use, self-efficacy in having discussions about mental health symptoms/ substance use, self-efficacy around connecting participant's child to mental health and/or addiction resources, (when appropriate) engagement with a provider for mental health and/or addiction care.
These will be assessed in the form of self-administered surveys and a qualitative exit interview.
|
From enrollment to the end of the surveys and exit interview at 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R21DA062071 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.